IMVT
Immunovant, Inc. · Healthcare
Director Andrew J. Fromkin sold $517K of Immunovant, Inc.
Sold$517,189
$23.25Price
22,249Shares
−21%Stake
What IMVT did after the filing
- The stock from Thu, Dec 4 open, $22.55
- +15.9%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Mon, Dec 1. Filed Wed, Dec 3, 6:14 PM ET, after the close. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.